Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 10529 - 10536 of 11617 results
Serial Relator Getting the Boot?
September 5, 2013| Blog| Viewpoint
More Courts Weigh In On The Controversy Of Using “All Natural” with GMOs
September 4, 2013| Blog| Viewpoint
ML Strategies Weekly Energy and Environment Update – Week of September 2, 2013
September 3, 2013| Blog| Viewpoint
Your Face is for Sale! The 4 Most Interesting Things About the Proposed Update to Facebook’s Governing Documents
September 3, 2013| Blog| Viewpoint
Broad Prop 65 Reform Going Nowhere -- Weaker Assembly Bill 227 Moving Forward
August 30, 2013| Blog| Viewpoint
Massachusetts’ Nascent Water Technology Cluster is Poised for Strong Growth
August 29, 2013| Blog| Viewpoint
A Continued Examination of Charitable Patient Assistance Programs- Part Seven in a Series: Charitable PAPs: Donations and Transparency
August 28, 2013| Alert| Viewpoint
Details that Matter – Personnel Changes in CPSC’s Offices of Compliance & Global Outreach
August 27, 2013| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.